Peter H Wiernik Selected Research

Peter H Wiernik Research Topics

Disease

18	Neoplasms (Cancer) 01/2018 - 03/2004
12	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 09/2003
12	Leukemia 01/2022 - 01/2004
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2016 - 01/2003
10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 01/2003
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2013 - 01/2003
8	Lymphoma (Lymphomas) 01/2016 - 01/2003
7	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 10/2008
6	Multiple Myeloma 08/2017 - 10/2008
6	Acute Promyelocytic Leukemia 03/2017 - 12/2002
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 03/2005
5	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 07/2012 - 07/2009
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2014 - 11/2009
4	Hodgkin Disease (Hodgkin's Disease) 03/2013 - 04/2006
4	Disease Progression 11/2009 - 02/2004
3	Renal Cell Carcinoma (Grawitz Tumor) 02/2021 - 12/2006
3	Philadelphia Chromosome 02/2017 - 05/2009
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2014 - 11/2009
3	B-Cell Lymphoma (Lymphoma, B Cell) 03/2013 - 02/2010
3	Prostatic Neoplasms (Prostate Cancer) 03/2011 - 06/2004
3	Thrombotic Thrombocytopenic Purpura 03/2005 - 01/2002
2	Melanoma (Melanoma, Malignant) 02/2021 - 03/2005
2	Kidney Neoplasms (Kidney Cancer) 01/2018 - 12/2005
2	Hemorrhage 03/2017 - 11/2004
2	Anemia 04/2016 - 07/2003
2	Hemolysis 04/2016 - 01/2002
2	Hypersensitivity (Allergy) 02/2016 - 11/2004
2	Blast Crisis (Blast Phase) 09/2010 - 05/2006
2	Neutropenia 01/2008 - 01/2005
2	Dermatitis 03/2007 - 11/2004
2	Adenocarcinoma 03/2007 - 01/2002
2	Carcinoma (Carcinomatosis) 03/2006 - 12/2005
2	Neoplasm Metastasis (Metastasis) 08/2005 - 06/2004
2	Splenomegaly 04/2004 - 07/2003
1	Hairy Cell Leukemia 01/2018
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2017
1	Pure Red-Cell Aplasia 04/2016
1	Polycythemia (Erythrocytosis) 02/2016
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016

Drug/Important Bio-Agent (IBA)

7	Rituximab (Mabthera)FDA Link 01/2017 - 11/2004
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2017 - 12/2002
5	Interleukin-2 (IL2)IBA 02/2021 - 03/2005
5	AntigensIBA 01/2018 - 08/2005
5	Lenalidomide (CC 5013)FDA Link 03/2013 - 12/2006
4	Transcription Factors (Transcription Factor)IBA 02/2012 - 07/2009
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2011 - 08/2003
4	Biological ProductsIBA 01/2008 - 04/2004
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 06/2004
3	Pharmaceutical PreparationsIBA 06/2012 - 11/2004
3	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2011 - 09/2003
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2010 - 01/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2004 - 01/2004
2	AndrogensIBA 01/2018 - 06/2004
2	Monoclonal AntibodiesIBA 01/2017 - 11/2009
2	Thalidomide (Thalomid)FDA Link 03/2013 - 04/2009
2	Antineoplastic Agents (Antineoplastics)IBA 03/2013 - 04/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2012 - 03/2007
2	AnthracyclinesIBA 12/2011 - 03/2004
2	fludarabineIBA 10/2011 - 01/2003
2	Tumor Biomarkers (Tumor Markers)IBA 03/2011 - 12/2005
2	Carboplatin (JM8)FDA LinkGeneric 09/2010 - 03/2007
2	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2010 - 04/2006
2	Vincristine (Oncovin)FDA LinkGeneric 10/2009 - 09/2003
2	Prednisone (Sone)FDA LinkGeneric 10/2009 - 09/2003
2	Immunoglobulins (Immunoglobulin)IBA 01/2008 - 03/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2007 - 01/2003
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2006 - 06/2004
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 12/2006 - 12/2005
2	thiamine triphosphorate (TTP)IBA 03/2005 - 01/2005
2	Etoposide (VP 16)FDA LinkGeneric 01/2005 - 08/2003
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 09/2004 - 08/2003
2	SteroidsIBA 04/2004 - 01/2002
1	ChromatinIBA 01/2022
1	CholesterolIBA 01/2022
1	Mevalonic Acid (Mevalonate)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 02/2017
1	CD20 AntigensIBA 01/2017
1	fms-Like Tyrosine Kinase 3IBA 10/2016
1	alvocidib (flavopiridol)IBA 06/2016
1	flavoneIBA 06/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2016
1	IronIBA 04/2016
1	Antiviral Agents (Antivirals)IBA 04/2016
1	Tyrosine (L-Tyrosine)FDA Link 02/2016
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 02/2016
1	Erythropoietin FDA Link 02/2016
1	telomerase RNA (bTR)IBA 01/2016

Therapy/Procedure

28	Therapeutics 01/2018 - 12/2002
14	Drug Therapy (Chemotherapy) 01/2017 - 02/2004
8	Cell Transplantation 01/2020 - 08/2011
7	Hematopoietic Stem Cell Transplantation 01/2018 - 02/2004
6	Transplantation 01/2018 - 03/2010
5	Homologous Transplantation 07/2013 - 02/2008
4	Autologous Transplantation 04/2015 - 02/2004
4	Aftercare (After-Treatment) 01/2008 - 01/2003
3	Stem Cell Transplantation 08/2011 - 08/2008
2	Immunotherapy 01/2016 - 02/2010
2	Radiotherapy 10/2009 - 03/2007
2	Induction Chemotherapy 05/2006 - 01/2004
2	Intravenous Infusions 01/2005 - 08/2003